Chris MacDonald

Chris MacDonald

Chris MacDonald is an MBA (finance) graduate with extensive experience covering small-, mid- and large-cap companies in the U.S. and Canadian markets. Chris is interesting in uncovering long-term and deep-value opportunities for investors based on principles from the Graham-Buffett school of thought, and looks forward to bringing investors a unique fundamental-based perspective on opportunities available in today’s challenging investing environment.

His experience as a financial analyst in the past, coupled with his fervor for finding undervalued growth opportunities, contribute to his conservative, long-term investing perspective.

Recent Articles

LCID Stock: 3 Big Reasons Lucid Motors Is Revving Up Today

Here are three reasons why investors in Lucid Motors and LCID stock are seeing impressive gains today, on an otherwise flat day.

FULC Stock: The Trial News Sending Fulcrum Therapeutics Skyrocketing

Shares of FULC stock are skyrocketing higher today on reports of positive results for the company's sickle cell treatment trial.

FCEL Stock: The $15M Reason FuelCell Energy Is Powering Up Today

Today, FCEL stock is on the move as the company announced financing for its fuel cell project on a U.S. submarine base.

HCMC Stock: What’s Going On With Healthier Choices Management Today?

Today, HCMC stock is on the move as investors price in a higher probability of the company winning its high-profile lawsuit.

CLOV Stock: One Big Reason Clover Health Is Squeezing Higher Today

Today, CLOV stock is on the move after Congress announced potential changes to the Medicare program that could expand the market.